Event Type
Disclosure
Mandatory
Variant
8-K
Entry Into a Material Definitive Agreement. As previously reported, Vivos Therapeutics, Inc., a Delaware corporation (the “ Company ”), entered into the followi
. The Inducement Warrants, the Inducement Warrant Shares, the Placement Agent Warrants, and the shares of Common Stock underlying the Placement Agent Warrants h
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Exhibit 4.1 Form of Series A Common Stock Purchase Warrant 4.2 Form of Series B Common Stock Purcha